Gra­cell gives sneak peek in­to leukemia CAR-T cell pro­gram ahead of EHA

Gra­cell Biotech­nolo­gies said Thurs­day af­ter­noon that its CAR-T treat­ment for pa­tients with B cell acute lym­phoblas­tic leukemia, or B-ALL, helped clear signs of can­cer in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER